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Photoresponses
Regulators of G protein signaling (RGS) constitute
a family of proteins that bind specifically to the acti-
vated a subunits of G proteins (Ga-GTP), acting as
GTPase activating proteins, or GAPs, for the rate of
GTP hydrolysis. In this issue of Neuron, Krispel et al.
resolve a long-standing puzzle in phototransduction,
establishing that RGS9 ‘‘GAPping’’ of Gta-GTP is the
molecular mechanism underlying the dominant recov-
ery time constant of mouse rod photoreceptors and
that a precise level of expression of RGS9 is required
for normal photoresponse timing.
RGS Proteins: GAPs for G Protein Signaling
The human genome contains more than 30 RGS genes
comprising six distinct families (Hollinger and Hepler,
2002). The core protein structure is a highly homologous
RGS domain that confers binding specificity for GPCR-
activated Ga-GTP. This RGS domain is flanked in differ-
ent subfamilies by domains that confer other features,
such as the ‘‘disheveled, EGL-10, pleckstrin’’ (DEP) ho-
mology domain, which determines subcellular localiza-
tion in subfamily R7, likely by binding a SNARE-family-
related protein such as R9AP (Martemyanov et al., 2003).
In many GPCR cascades, the receptor (R*) and the ef-
fector (E*) are enzymes and act as amplifiers of signaling;
in contrast, the intermediate (G* = Ga-GTP) that activates
E* has 1:1 stoichiometry with it, and does not amplify
(Figure 1A). The instantaneous signal strength at each
of the first three cascade steps can be identified with
the number of activated protein molecules of each spe-
cies at a given moment. RGSs modulate the signal
strength not by altering the number of molecules acti-
vated per unit time as GPCRs do, but rather by acting
as GAPs to control the G* lifetime. A fundamentally im-
portantcontribution ofKrispel etal.’s investigation is their
thoroughly convincing evidence that the concentration
determines RGS9 GAP activity in rods (their Figure 3F).
To appreciate the broad significance of this result,
some background on GPCR signaling in rods is helpful.
Phototransduction: GPCR Cascade Signaling
with Two Time Constants
Krispel et al.’s investigation contributes to a rich tradi-
tion of using rods for investigating quantitative aspects
GPCR signaling. The initial steps of the rod cascade fol-
low the classic pattern (Figure 1A): the light-activated
GPCR, rhodopsin (R*), activates a rod-specific G pro-
tein, transducin (Gt), whose activated a subunit (G* =
Gta-GTP) stoichiometrically activates one catalytic sub-
unit (E*) of the rod phosphodiesterase (PDE) by relieving
the inhibition of a g subunit (PDEg). The hydrolysis of
cGMP by E* decreases the inward cationic current
through cGMP-gated channels, leading to membrane
hyperpolarization. Signal amplification is a property of
the activation phase of the response, and its molecularbasis is now well understood: it is achieved primarily
by the actions of R* and E*, with the cooperative gating
of the cyclic nucleotide-gated channels contributing an
additional factor (Lamb and Pugh, 1992; Pugh and
Lamb, 1993; Leskov et al., 2000). In contrast, problems
remain in understanding the molecular mechanisms
governing inactivation and recovery. Perhaps none has
been more resistant to resolution than the molecular
identity of the so-called ‘‘dominant recovery time con-
stant’’ or ‘‘rate-limiting step’’ in recovery. For insight
into this problem, it is helpful to consider a schematic
of the cascade (Figure 1A). Theoretical models that treat
the first three steps of phototransduction as a linear cas-
cade, with the molecular amplifiers R* and E* inactivat-
ing with first-order time constants tR and tE, respec-
tively, have provided a good description of the flash
responses of rods under a variety of conditions (Nikonov
et al., 1998; Hamer, 2000). However successful, such
models have an inherent ambiguity: the values assigned
to tR and tE are interchangeable without altering the
predictions of response kinetics. A potential resolution
of this ambiguity comes from systems analysis, which
shows that in any linear reaction cascade, the longest
time constant will be rate limiting and completely govern
the decay of the response at sufficiently long times after
a brief activation (see, e.g., Nikonov et al., 1998). The
proviso for achieving this resolution is that an experi-
ment must be designed that uniquely manipulates the
molecular step hypothesized to be dominant or rate lim-
iting. In the special case in which there are only two time
constants—which can be symbolized as tD (‘‘domi-
nant’’) and tND (‘‘nondominant’’)—identification of the
molecular mechanism underlying tD also determines
the identity of the mechanism underlying tND by default.
Pepperberg’s Inactivation Time Constant
Pepperberg et al. (1992) discovered a remarkable fea-
ture of amphibian rod light responses: the recovery of
the cGMP-mediated current after a series of saturating
flashes of increasing intensity was found to be displaced
laterally in time, about 2–2.5 s per e-fold increase in in-
tensity; the semilog ‘‘Pepperberg plot’’ of displacement
versus intensity readily extracted this critical parameter,
tc, which in mouse is 200–250 ms (Lyubarsky and Pugh,
1996; cf. Figures 2D and 3E of Krispel et al., 2006). Pep-
perberg et al. argued that tc estimated the ‘‘dominant re-
covery time constant’’ (labeled above and hereafter
as tD) of the disc-associated reactions (steps 1–3 of
Figure 1A); they also argued that their data supported
the hypothesis tD = tR, i.e., that the lifetime of R* is the
dominant or rate-limiting step of inactivation. A contro-
versy developed, however, as doubts were subse-
quently cast on the hypothesis by investigations charac-
terizing functional properties of tD and tND. Notable
among these were calcium-clamp experiments: one
set showed that tD is not affected by the decline in intra-
cellular calcium (Ca2+i) that accompanies the light re-
sponse (Lyubarsky et al., 1996), while others with rapid
solution-exchange clamping provided evidence that
tND is sensitive to Ca
2+
i in a manner consistent with the
hypothesis that the molecular mechanism underlying
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(Matthews, 1997). This latter hypothesis was later shown
to be quantitatively consistent with the biochemical
properties of recoverin’s calcium-dependent inhibition
of rhodopsin phosphorylation (Nikonov et al., 2000).
The controversy regarding the identity of the molecular
mechanism underlying tD has resisted resolution for al-
most 15 years, with different phototransduction labs
presenting results and arguments in favor of tR or tE. A
critical experiment was needed to definitively distin-
guish between the two hypotheses, and it became clear
that such an experiment should meet two criteria: (1) it
should involve a manipulation established biochemi-
cally to target exclusively (and incontrovertibly) the inac-
tivation of R* or E*; (2) it should produce robust evidence
that this manipulation reduces the Pepperberg con-
stant, tD. (The rationale for the second criterion is that
manipulations that increase tD could do so by causing
the nondominant mechanism to become dominant.)
Krispel et al. (2006) have executed and in this issue of
Neuron present the results of such a critical experiment.
Figure 1. The Phototransduction GPCR Cascade and the Molecular
Mechanism of the Rate-Limiting Step of Recovery
(A) Schematic of phototransduction cascade. In step 1, light isomer-
izes rhodopsin, creating R*. Steps 1–3 are similar in many GPCR
cascades: R* activates a specific G protein, creating the activated
intermediate G* (=Ga-GTP) (step 1); a G* stoichiometrically activates
one of the two catalytic subunits of the tetrameric phospho-diester-
ase (PDE), creating E* (step 2); E* catalyzes the hydrolysis of cG (cy-
clic GMP) (step 3), which holds open cyclic nucleotide-gated chan-
nels (CNGCs) in the dark, and which close as cG is reduced by E*s;
the resting cG level is set by the balance of synthesis by guanylyl cy-
clase (GC) and PDE hydrolysis. Models of phototransduction in
which R* and E* inactivation are characterized by first-order decays
with time constants tR and tE, respectively (red arrows), have been
successful in providing quantitative descriptions of rod photores-
ponses (see text for details). (B) Molecular mechanism underlying
tE: E*s activated by G* encounter R9AP-RGS9-Gb5, leading to for-
mation of the ‘‘GAP complex,’’ in which RGS9 facilitates hydrolysis
of GTP after G* has bound to and activated E*.Resolution of the Controversy of the Rate-Limiting
Step of Rod Inactivation
The central result of Krispel et al. (2006) is presented in
their Figure 3. The data in this figure establish that in
mouse rods overexpressing RGS9 the ‘‘Pepperberg
constant’’ tD is highly reliably reduced from its normal
value of 250 ms down to 75 ms. As the manipulation of
RGS9 overexpression uniquely targets E* (Figure 1B),
it meets criterion (1); and as tD is reduced by RGS9 over-
expression, criterion (2) is also met. Thus, it can be
unequivocally and definitively concluded that tD = tE,
i.e., that the rate-limiting inactivation step of the rod
phototransduction cascade is the ‘‘GAPping’’ of GTP
hydrolysis in the quaternary protein complex, Gb5-
RGS9-(Gt-GTP)-PDEg (Figure 1B). Krispel et al. further
strengthen this conclusion by showing that a lowered
level of RGS9 leads to an increased tD and that molecu-
lar manipulations aimed at speeding R* shutoff have
no reliable effect on tD. Thus, the overall recovery time
course can be made faster or slower, depending upon
whether RGS9 is over- or underexpressed. Above
3-fold overexpression, the effect of RGS9 in reducing
the Pepperberg constant saturates, with an asymptotic
value tD = 75 ms. The natural interpretation of this result
is that, as tE becomes smaller and smaller, the previ-
ously non-rate-limiting decay of R* activity becomes
dominant: and so, the data yield the estimate tR = 75 ms.
These results are a landmark in phototransduction re-
search because they not only unambiguously identify
RGS-mediated GAPing of the E* complex as the rate-
limiting step for rod response recovery but also because
they provide, for the first time, an experimental estimate
of tR. From a larger perspective, the meticulous, quanti-
tative analysis by Krispel et al. of the effect of the level of
expression of a transgene on a quantitative physiological
parameter raises the bar for future targeted gene manip-
ulations and invites novel hypotheses about the role of
expression level in determining the function of an RGS.
RGS Concentration Matters
Experiments utilizing gene knockout approaches gener-
ally yield only three levels of expression of the protein
product of the targeted gene: normal (wt), null (2/2), and
one intermediate value (+/2). The inferences to be drawn
are relatively simple: ‘‘this protein is essential for that
function’’ (2/2 versus wt) and/or ‘‘normal levels of this
protein are required for that function’’ (+/2 versus wt). In
contrast, Krispel et al. (2006) generated transgenic mouse
lines with six different levels of RGS9, confirmed normal
expression levels of other critical transduction proteins
in each line, and then measured tD, a quantitative charac-
teristic of cascade inactivation, in adequate populations
of rods from each line. The result is a powerful dose-
response relationship for tE versus RGS9 in situ, where
the other proteins are present in their native concentra-
tions (cf. Krispel et al.’s Figure 3F). A remarkable feature
of this dose-response relationship is that mere 2-fold
changes in RGS9 expression up or down from its normal
level highly reliably alter tD in a corresponding manner.
How does RGS9 concentration exert such a powerful
influence on the effector (E*) lifetime? Two non-mutually
exclusive hypotheses can be put forward. First, the
speed of the GAP reaction may be governed by the time
taken for RGS9-Gb5, anchored to the membrane by
R9AP, to diffuse to, bind to, and form the effective GAP
Not Too Excited?
Thank Your Endocannabinoids
Endocannabinoids can mediate neuroprotection, but
it is not known how. In this issue of Neuron, Monory
et al. use mutant mice and localized viral targeting to
produce conditional knockouts of the cannabinoid
CB1 receptor. They show that protection against
kainic acid-induced seizures and cell death is con-
ferred by CB1Rs on hippocampal glutamatergic nerve
terminals.
Epileptic seizures reflect states of pathological hyperex-
citability and hypersynchronous activity in large neuro-
nal networks. Broadly speaking, seizures arise from an
imbalance of two fundamental antagonistic neuronal
motive forces—excitation and inhibition—toward exci-
tation. But the underlying mechanisms may be very
complex and, in addition to alterations in the strength
of excitatory and inhibitory chemical synapses, may
involve electrical gap junctions, neuronal network oscil-
lations, and rewiring of the neuronal circuits. The hippo-
campus is one of the most seizure-prone brain regions,
perhaps because it typically rests near the tipping point
of the balance and is susceptible to numerous forms of
plasticity. Whatever their etiology, seizures are highly
disruptive to normal brain functions, and if severe and
prolonged, can lead to very bad outcomes, including
neuronal cell death. Intrinsic biological mechanisms
that protect against seizures are therefore of great theo-
retical and practical interest.
Endogenous cannabinoids (‘‘endocannabinoids’’) are
the natural agonists of membrane-bound, G protein-
coupled receptors that mediate the actions of drugs,
such as marijuana, derived from the cannabis plants.
The principal cannabinoid receptor subtype in the
CNS, CB1R, is predominantly localized on or near syn-
aptic terminals, and its activation inhibits synaptic trans-
mitter release. The two major endocannabinoids are
arachidonyl-ethanolamide (anandamide) and 2-arachi-
donyl glycerol (2-AG). They are produced by neuronal
enzymatic activity and generally serve as intercellular
messengers, often traveling in the ‘‘retrograde’’ direc-
tion to the incoming synaptic input. CB1Rs are widely
dispersed throughout the brain in specific association
with well-defined cell types in the different regions,
and this accounts for the variety of behavioral effects
caused by the exogenous cannabinoids. Several years
ago, Panikashvili et al. (2001) reported that experimental
closed-head injury produced an elevation in 2-AG and
that exogenous administration of 2-AG reduced the
brain edema and hippocampal cell death associated
with such injuries. This was direct in vivo evidence for
a neuroprotective effect of an endocannabinoid. In this
issue of Neuron, Monory et al. (2006) now ask and an-
swer novel questions about the cellular mechanisms of
endocannabinoid-mediated neuroprotection.
In an earlier investigation, Lutz, Marsicano, and
colleagues (Marsicano et al., 2003) reported that mice
lacking CB1 (CB12/2) experienced kainic acid (KA)-
induced seizures that were much more severe than
those experienced by wt or heterozygotic CB1+/2
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393complex (Figure 1B). Second, the second-order binding
reaction for GAP complex formation may be weak and,
thus, driven faster by elevated concentrations of RGS9.
Testing these hypotheses will yield new information
about the cellular and molecular details of RGS function.
Implications for Non-Retinal Neuronal Timing Circuits
and for Therapeutics
GPCR cascades are implicated in a variety of neuronal
circuits with strict timing requirements: for example, the
basal ganglia are widely understood to be involved in
precision timing of locomotion and other behaviors, and
evidence has been presented that a splice variant of
the photoreceptor RGS, RGS9-2, acting through dopa-
minergic D1 and D2 GPCR cascades, modulates psy-
chostimulant-induced locomotion and reward behavior
(Rahman et al., 2003). One important implication of the
experiments of Krispel et al. is that the expression levels
of different RGSs in specific neuronal subpopulations
are likely to be tightly regulated in order to achieve preci-
sion timing of behavior. Another implication of broad
significance is that the expression levels per se of RGSs
may become proper targets for therapeutic interventions
in diseases of such timing circuits. In sum, the bottom
line is simple and powerful: RGS expression levels are
critical for timing, and in GPCR signaling ‘‘timing is every-
thing’’ (Shea et al., 2000).
Edward N. Pugh, Jr.1
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